UK markets open in 5 hours 8 minutes

Oncternal Therapeutics, Inc. (GTU.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0000-6.5200 (-100.00%)
At close: 09:00AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-36,380
-39,479
-44,170
-31,333
-17,225
-
Stock-based compensation
6,975
7,500
7,431
5,875
1,556
-
Change in working capital
2,102
1,274
-69
-1,300
-1,675
-
Accounts payable
-502
-1,769
958
816
272
-
Other working capital
-28,633
-32,164
-36,704
-26,589
-17,495
-
Other non-cash items
170
174
179
169
150
-
Net cash provided by operating activities
-28,633
-32,164
-36,704
-26,589
-17,495
-
Cash flows from investing activities
Acquisitions, net
-2,155
-
-
-
-
-2,155
Purchases of investments
-52,327
-64,349
-26,498
0
-
-
Sales/maturities of investments
76,250
65,000
0
-
-
-
Net cash used for investing activities
16,137
651
-26,498
0
-
16,137
Cash flows from financing activities
Common stock issued
0
1,224
9,582
0
113,876
-
Common stock repurchased
-138
-156
-3
0
-
-
Net cash used provided by (used for) financing activities
-138
1,068
9,579
617
114,181
-
Net change in cash
-4,848
-30,445
-53,623
-25,972
96,686
-
Cash at beginning of period
11,244
37,142
90,765
116,737
20,051
-
Cash at end of period
6,396
6,697
37,142
90,765
116,737
-
Free cash flow
Operating cash flow
-28,633
-32,164
-36,704
-26,589
-17,495
-
Free cash flow
-28,633
-32,164
-36,704
-26,589
-17,495
-